Medicamentos huérfanos

by Juan Manuel Fontanet Sacristán, Josep Torrent-Farnell
Published 2018-09-01

Implementing reflective multicriteria decision analysis (MCDA) to assess orphan drugs value in the Catalan Health Service (CatSalut)

by Laura Guarga, Xavier Badia, Mercè Obach, Manel Fontanet, Alba Prat, Atonio Vallano, Josep Torrent, Caridad Pontes
Published 2019-06-01

Evidence supporting regulatory-decision making on orphan medicinal products authorisation in Europe: methodological uncertainties

by Caridad Pontes, Juan Manuel Fontanet, Roser Vives, Aranzazu Sancho, Mònica Gómez-Valent, José Ríos, Rosa Morros, Jorge Martinalbo, Martin Posch, Armin Koch, Kit Roes, Katrien Oude Rengerink, Josep Torrent-Farnell, Ferran Torres
Published 2018-11-01